Comprehensive real-time dashboard tracking breakthrough Type 1 diabetes vaccines and immunotherapies. Monitor teplizumab (FDA-approved), BCG vaccine trials, GAD65, insulin peptide vaccines, and revolutionary beta cell preservation strategies.
Teplizumab - first disease-modifying therapy approved for T1D prevention in 2022
Large confirmatory trials testing efficacy for regulatory approval
Expanded safety and preliminary efficacy evaluation
First-in-human safety testing and dose-finding studies